๐ฐ Final Analysis News
Page 3 - Final Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Final Analysis. Real-time updates on events, politics, business and more.
August 27, 2022
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the final results from the randomized Phase 2 GRIFFIN study...
August 27, 2022
Data featured in plenary session at the 19th International Myeloma Society Annual Meeting LOS ANGELES, Aug. 27, 2022 /PRNewswire/ -- The Janssen P...
June 10, 2022
- Long-term data at the European Hematology Association (EHA) 2022 Congress expands understanding of the impact of Genentech medicines in early-stage blood cancers with the goal of providing patients
May 10, 2022
10.05.2022 - New clinical results from MORNINGSKY trial shows 71% reduction in hospitalization (secondary endpoint) in broad patient population with COVID-19 treated with bemnifosbuvir (AT-527) versus placebo (p=0.047, unadjusted, exploratory) New clinical ...
March 29, 2022
-- AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectru...
March 26, 2022
Award-winning vocalist and recording artist Nicolas Beard is known for his silky baritone and jazz-inflected R&B.
March 1, 2022
The Times of Central Asia - central asia news - Publishing by Blackwood Press, Founder by Giorgio Fiacconi
December 23, 2021
The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate coronavirus vacc
December 23, 2021
The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate coronavirus vacc
November 4, 2021
The controversial film was lambasted by feminists as glamourising โrape with moneyโ. So why is a musical adaptation coming back for more?